Skip Navigation

Department of Microbiology and Immunology

Dr. Tomlinson Receives R21/R33 from NIH/NINDS

Dr. Steve Tomlinson was awarded a R21/R33 grant from NIH/NINDS titled, “Complement inhibitors targeted to the ischemic brain for the treatment of stroke.” Stroke is the fourth leading cause of death in the United States and the main cause of long-term disability, and there is a significant unmet need for new and effective approaches to treat stroke. The long-term goal of these studies is to identify and develop an effective and safe therapy to improve functional outcome after stroke. 


© Medical University of South Carolina | Disclaimer